R. Rabah et al., Human papillomavirus-11-associated recurrent respiratory papillomatosis ismore aggressive than human papillomavirus-6-associated disease, PEDIATR D P, 4(1), 2001, pp. 68-72
The aim of this study was to determine whether viral type (HPV-6 vs. HPV-II
) could predict the clinical course of recurrent respiratory papillomatosis
in children. Viral typing, using the polymerase chain reaction, was perfor
med on laryngeal biopsies of 61 patients treated at Children's Hospital of
Michigan. HPV-6 was detected in 29 of the patients' biopsies and HPV-11 in
32 biopsies. HPV-II was more common among the African-American patients tha
n among Caucasians (P = 0.001). Patients with HPV-11 were diagnosed at a yo
unger age (36.2 vs. 48.2 months; P = 0.04) and were more likely to have act
ive disease (P = 0.0311) at the time of this study. They tended to have lon
ger periods of disease activity (8 years vs. 5 years; P = 0.026), required
more surgical procedures (42 procedures/patient vs. 13.6; P = 0.02), and mo
re procedures per patient, per year (2.9 vs. 5.3; P = 0.0164). Three of the
patients infected with HPV-11 developed invasive papillomatosis and bronch
ogenic squamous cell carcinoma, and two of these patients died of disease.
Our findings suggest that HPV-11 infection confers a more aggressive course
to recurrent respiratory papillomatosis.